Drug company secretly briefed medical societies on HRTBMJ 2003; 326 doi: http://dx.doi.org/10.1136/bmj.326.7400.1161 (Published 29 May 2003) Cite this as: BMJ 2003;326:1161
- Ray Moynihan
- Washington, DC
Pharmaceutical giant Wyeth has admitted that it secretly briefed a number of medical societies about the results of a study into hormone replacement therapy (HRT) and dementia before they were published this week.
On Wednesday JAMA published the study, funded by Wyeth, which shows that the company's combined oestrogen and progestogen pill doubled the risk of dementia among elderly women from about 1% to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial